Prelude Capital Management’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248K Sell
6,439
-3,516
-35% -$146K 0.02% 803
2025
Q4
$462K Buy
9,955
+3,332
+50% +$160K 0.03% 572
2025
Q3
$325K Sell
6,623
-2,665
-29% -$139K 0.03% 695
2025
Q2
$481K Buy
+9,288
New +$375K 0.05% 458

Other funds holding HNGE

Prelude Capital Management's HNGE Position: Q1 2026 in Review

Prelude Capital Management reduced its Hinge Health (HNGE) stake by 35% in Q1 2026, selling an estimated $146K and leaving 6,439 shares worth $248K. The position accounts for 0.02% of the portfolio, ranked #803.

Prelude Capital Management first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $481K in Q2 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Prelude Capital Management held 6,439 shares of Hinge Health worth $248K as of Q1 2026.
  • Prelude Capital Management sold 3,516 Hinge Health shares in Q1 2026, an estimated $146K.
  • Hinge Health made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #803 holding.
  • Prelude Capital Management first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • Prelude Capital Management's Hinge Health position peaked at $481K in Q2 2025.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.